Background Malignancy is the leading cause of death in Hong Kong, and lung cancer tops the list of all cancer deaths.
Introduction
Malignancy is the leading cause of death in Hong Kong, and lung cancer tops the list of all cancer deaths. 1 Smoking is a well-known cause of lung cancer. [2] [3] Recent data also incriminate obstructive lung disease, chronic obstructive pulmonary disease [4] [5] and asthma 6 as risk factors. Body mass index (BMI) appears to play a role, but the results are sometimes conflicting and might be intractably confounded among ever-and never-smokers. [7] [8] [9] [10] [11] [12] [13] As BMIs and obstructive lung disease are closely related to smoking, 14, 15 residual confounding by smoking may be a valid concern, despite adjustment for these variables by multivariate modelling. Substantial differences in the epidemiology of lung cancer have also been observed between genders, even though some of them could be partly attributed to differences in smoking patterns. 16, 17 There is also increasing evidence, from analysis of lung cancer genomes or genetic expression, that the predominant genetic and epigenetic alterations differ significantly between smokers and non-smokers. 18, 19 Significant ethnic or regional variations in the rates and patterns of lung cancer have also been observed. 20 Data on the effect of BMI on lung cancer in Asian populations are notably scarce. Lung cancer is the leading cause of cancer death in Hong Kong Chinese women, even though few of them smoke, 1 and the local female lung cancer death rate is also one of the highest in the world. 21 It would therefore be desirable to examine, in more detail, the effect of BMI on lung cancer mortality in this Asian population.
Methods
The Elderly Health Service provides a communitybased health maintenance program to the elderly through 18 centres in Hong Kong and we have previously used this database for several prospective studies. 14, 22, 23 For each client on enrolment, a trained nurse administers a standardized questionnaire and measures body weight and height. The questionnaire is followed by history-taking, medical examination by a family physician and chest X-ray examination is arranged as needed. The key variables are entered into a structured database, and regularly checked for completeness. A cohort of clients who enrolled at the 18 elderly health centres from 1 January 2000 to 31 December 2003 was retrospectively assembled as previously reported. 14, 22, 23 The date of enrolment, name, sex, age, Hong Kong Identity Card number, smoking status, passive smoking, alcohol use, language spoken, education level, marital status, housing situation, public means-tested financial assistance status, co-existing medical conditions, activities of daily living (ADL) score, geriatric depression scale (GDS) score, family history of malignancy, body height, weight and recent weight loss of 55% within 6 months were retrieved from the baseline health assessment database.
A never-smoker was defined as one who had never smoked or smoked as few as one cigarette a day or equivalent for the duration of 1 year. An ever-smoker was defined as one who had smoked at least one cigarette a day for at least 1 year. Passive smoking was defined as passive exposure to tobacco smoke within the same household. A regular drinker and a social drinker were defined as one who drank on 54 days per week and on 43 days per week, respectively. An ex-drinker referred to a regular or social drinker who had stopped drinking. A never drinker was defined as one who had never been a regular or social drinker. The BMI was classified into the following categories: <18.5 (underweight); 18.5 to <23 (normal); 23 to <25 (at risk); 25 to <30 (overweight); 530 (obese), in line with the WHO expert consultation on the appropriate body mass index for Asian populations. 24 Obstructive lung disease was defined as physician-diagnosed chronic obstructive pulmonary disease (COPD) or asthma.
All subjects with suspected cancer, significant weight loss of 45% within the past 6 months or obstructive lung disease at the baseline were excluded. The baseline database was cross-matched prospectively with the death registry using the identity card number as identifier, supplemented by name and age, from enrolment to 31 The study was designed to maximize the number of subjects to be included from the database of the Elderly Health Service to allow effective analysis and control of possible confounders. Univariate analysis was first performed to analyse the relationship between all baseline variables and mortality due to lung cancer, other tobacco-related malignancies and non-tobacco-related malignancies. Chi square and Fisher's exact tests were used as appropriate for categorical variables, and analysis of variance was used for numerical variables. These were followed by Cox proportional hazards analysis, with adjustment for sex, age, smoking status and other baseline variables. The proportional hazard assumption of the Cox model was assessed by inspection of the log minus log curve. To address the issue of reverse causality, sensitivity analysis was performed by excluding deaths within the first years. Potential interaction and multi-collinearity were also considered. To exclude residual confounding effects by smoking, subgroup analyses were employed to examine the effects of BMI among never-smokers and ever-smokers separately. 
Results
A total of 64 574 clients aged 565 years were recruited from 2000 to 2003, after exclusion of 590 cases with missing or invalid identity card numbers or missing/incomplete information on sex, age, smoking status, weight and/or height. Further to that, 347 subjects with known/suspected cancer on presentation, 1696 with loss of 45% body weight within 6 months, 3598 subjects with obstructive lung diseases and 2 other subjects who died within 3 months were also excluded, leaving 58 931 subjects for analysis.
The background data were 499.9% complete for the variables listed in Table 1 . The vast majority (98.2%) per 100 000 person-years for females. Among male never-smokers, the crude lung cancer death rate was 115 (89-146) per 100 000, which was similar to the corresponding rate of 145 (130-160) per 100 000 among female never-smokers (P ¼ 0.088). Table 2 shows the mortality due to lung cancer, tobacco-related malignancies and non-tobacco-related malignancies by sex, age and BMI. There was a clear sex-and age-dependent trend in mortality for all three types of malignancies. The effect of BMI was evident mainly for mortality due to lung cancer and other tobacco-related malignancies. Table 3 shows similar analyses after stratification by ever-smoking status. After such stratification, the effect of gender on lung cancer mortality was no longer observed. The effect of BMI on lung cancer mortality was preserved among both ever-and never-smokers, whereas its effect on mortality due to other tobaccorelated malignancies was only evident among ever-smokers. Table 4 shows the results of Cox proportional hazard analyses on cancer death risks. In the overall model, there was a progressive decrease in lung cancer deaths across the five BMI categories (from underweight to obesity) after adjustment for sex, age, smoking status and all other baseline variables as listed in Table 1 . Figure 1 shows the adjusted hazards of lung cancer deaths among different baseline BMI categories in the overall model. Such a gradient was absent for other tobacco-related deaths and non-tobacco-related malignancies. As shown in the same table, very similar results were observed in the Cox proportional hazard analysis among never-smokers. Among ever-smokers, BMI did show an effect on other tobacco-malignancies as well, but mainly for an excess death risk among those underweight. Table 5 shows the results of sensitivity analysis, with repetition of the Cox proportional hazard analyses on lung cancer deaths after exclusion of deaths within the initial 3 years. Consistent trends in the hazard ratios (HRs) were observed across the BMI categories after such exclusion in the overall model and after stratification by ever-smoking status, although the P-value was 40.05 among eversmokers. 
OBESITY AND LUNG CANCER

Discussion
In this study, after exclusion and/or adjustment for potential confounders, BMI was independently (and negatively) associated with death from lung cancer. Obesity with BMI 530 (adjusted HR, 0.55, 95% CI 0.38-0.80) was associated with reduced lung cancer mortality, which was more prominent than the opposing effect of underweight (adjusted HR, 1.38, 95% CI 1.05-1.79). The association between obesity and reduced mortality was relatively specific for lung cancer deaths, with only a minor or no effect of obesity on other smoking-related malignancies and non-tobacco-related malignancies (Table 4 ).
An inverse relationship was found between BMI and lung cancer deaths among both smokers and non-smokers in our study. Several previous cohort studies found an increased risk of lung cancer with leanness mainly among smokers. 7, 8, [10] [11] [12] [13] There were also some notable null results after exclusion of smokers. [8] [9] [10] [11] [12] [13] 25 The failure to detect a significant relationship between BMI and lung cancer mortality in some of the previous studies could be attributed partly to a type-II error because of the much lower lung cancer incidence among never-smokers. 2, 3 In our study, elderly subjects with high cancer mortality were studied. Over 70% of the subjects were never-smokers because of the predominance of females. A high incidence of lung cancer has also been reported among never-smoking females in Hong Kong. 1, 21 With 454 (42%) of the lung cancer deaths recorded among never-smokers in this study, a significant inverse relationship between BMI and lung cancer deaths was observed even among this relatively lowrisk group. This observation also effectively rules out the potential confounding effect of smoking on the association between BMI and lung cancer mortality.
Most of the previous studies reported just on lung cancer and not on other cancers as well. 7, 11, 13, 26, 27 In our study, an attempt was also made to assess the effect of BMI on other tobacco-related and nontobacco-related malignancies simultaneously. Obesity was associated with reduced lung cancer mortality, but not mortality due to other malignancies (Table 4) . Even for other tobacco-related malignancies, mortality increased only among the underweight, and obesity did not exert any significant effect. These results suggest a specific effect of BMI on lung cancer risk, rather a general effect on mortality as a whole. 28 No information is available on the exposure to cooking fumes in this study. In a previous case-control study in Hong Kong, smoking and cooking fume exposure seem to act independently on lung cancer risk. 29 However, in order for cooking fume exposure to confound the negative association between BMI and lung cancer in its study, cooking fume exposure has to be sufficiently and negatively associated with BMI. As cooking may be associated with eating habit and food availability, a strong negative association Alternative approaches have been attempted to examine the relationship between BMI and mortality. In a large intergenerational study there was a positive, rather than negative, association between offspring BMI and lung cancer mortality in mothers and fathers. 30 On the other hand, in another study using a Mendelian randomization approach, 31 the fat mass and obesity associated gene (FTO) A allele, which is linked with increased BMI, was associated with a decreased risk of lung cancer. While these intergenerational or genetic studies might allow genetic variation to act as an unconfounded marker of environmentally modifiable factors and offer the potential to obtain estimates of the causal effect of obesity, the indirect inference could, itself, be confounded by the numerous factors that might affect the less than perfect association between the parental characteristics or genotypes and the BMI of the very subjects under consideration in the relevant period of time.
In this study, we further divided the elderly subjects into five BMI categories in line with the WHO recommended Asian standard, and the effect of each BMI category was compared with the normal BMI category of 18.5 to <23. Besides the specific and consistent inverse relationship observed between BMI and lung cancer mortality, obesity and overweight also showed a protective effect comparable with, or even more prominent than, the deleterious effect of underweight. The protective effect of obesity is rather complex and no ready explanation could be found. However, a similar effect has also been observed for pulmonary (but not extrapulmonary) tuberculosis 14 and, to a lesser extent, other respiratory mortalities. 12 It is uncertain whether some form(s) of enhanced immune surveillance could underlie such associations. The predominant manifestations of an immunity-based protective effect on pulmonary pathologies could also have an evolutionary basis, because the respiratory system in higher animals is constantly exposed to potentially harmful influences from the outside environment. Further studies are needed to sort out the exact underlying mechanism(s). This is a study on a cohort of elderly in the community setting. The relatively better health of noninstitutionalized clients helped to minimize the masking effects of other competing causes of death. The higher incidence of lung cancer and other malignancies among the elderly as a whole provided an adequate number of endpoint events for subgroup analysis. While our cohort had a lower percentage of male subjects in comparison with the 2001 census (35.5 vs 46.2%), 32 the lung cancer death rates of 347/100 000 among males and 169/100 000 in females were largely comparable with the reported lung cancer death rates among subjects of the same age (395/100 000 among males and 132/100 000 among females aged 70-74 years in 2006) in the Hong Kong population. 33 Because of logistic difficulty in clinically following up a large cohort over a prolonged period, mortality due to lung cancer was examined, rather than incidence of the condition itself. However, lung cancer carries a very high mortality with median survival only in the region of 1 year. 34 Lung cancer deaths are therefore likely to provide fairly accurate information on the incidence of the disease. Under-reporting of death could be a potential source of concern. However, Hong Kong has a welldeveloped health-care infrastructure. With ready access to both primary and secondary care, most if not all lung cancer deaths occurred in well-equipped hospitals with good diagnostic facilities. Misclassification between primary and secondary lung cancers should be rare. There is also a fully functional death registration system. Medical practitioners are required by law to refer all cases with unknown causes of death to the coroner. Wherever necessary, post-mortem examination is performed to ascertain the cause of death. Furthermore, all adult legal residents are provided with an identity card number, which is widely adopted as a unique identifier in all statutory registration systems, and this has greatly facilitated tracking of all deaths in our study. As we examined the differences between subgroups in this cohort, there should be good internal validity. All subjects with physician-diagnosed obstructive lung disease at the baseline were excluded in this study to avoid its potentially complex interaction with smoking, BMI and mortality. 35 To minimize any concern over reverse causality, a prospective follow-up design was adopted, and all subjects having suspected malignancies or significant weight loss at baseline were also excluded. In the principal analysis, all deaths occurring within 3 months of registration were discarded. As shown in Figure 1 , lung cancer deaths occurred fairly uniformly throughout the prospective 8 years of follow-up. BMI also showed consistent effects on lung cancer mortality in sensitivity analyses after excluding deaths within the initial 3 years. However, younger subjects are not eligible for recruitment into our Elderly Health Program. Further studies on younger subjects are warranted.
